An IQVIA report published earlier this year found that 43% of anti-obesity assets currently in development are orally ...

Biotech firm Ascletis Pharma said ASC47, its muscle-preserving weight loss drug candidate, could boost the efficacy of the ...

Researchers in Denmark observed a significant drop-off in anti-obesity drug usage after 1 year in first-time users.

Scientists discovered that people taking weight loss medications regained pounds weeks after they stopped taking the drugs. More than 1,000 people participated in a study and their lifestyle habits ...

Experts in Europe are concerned about what the global GLP-1 agonist excitement could mean for childhood obesity, which can ...

A new USC Schaeffer Center white paper finds expanded access to anti-obesity medications would lead to significant increases in life expectancy and disease-free years while generating a substantial ...

WASHINGTON—The American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to improve access to anti-obesity medications. In the resolution, the AMA committed ...

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says Hamlet Gasoyan, PhD, Cleveland Clinic. Hamlet Gasoyan, PhD, researcher at the ...

"Given the escalating obesity rates, especially severe obesity among women, and the growing popularity of anti-obesity medications, exploring the association between anti-obesity medication and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Phentermine greatly helped patients who responded poorly ...